CP Medical, a wholly-owned subsidiary of Theragenics has launched its “PLUS” line of antibacterial sutures for use in the veterinary market. The initial PLUS line includes the popular Visorb, Monoswift, and Mono-Dox sutures, now available with the antibacterial coating, chlorhexidine diacetate.
Chlorhexidine diacetate is an antibacterial agent that is effective against a variety of bacteria, including Staphylococcus aureus, Staphylococcus epidermidis, MRSA and MRSE. In suture, chlorhexidine greatly diminishes the ability of bacteria to colonize on the suture at the surgical site. The antibacterial coating does not change the feel, handling or performance of the sutures.
“Post-surgical infections of both humans and pets remain a significant concern to healthcare providers. Veterinary professionals are continually looking for products that improve the surgical outcomes of the animals in their care. This product line shows our commitment to providing veterinarians with innovative, niche products in growing markets. These types of products will continue to be a focus for us in the future,” said M Christine Jacobs, chairman and chief executive officer of Theragenics Corporation.
Mono-Dox Plus is an antibacterial-coated polydioxanone synthetic absorbable, sterile, monofilament surgical suture. This suture features extended holding strength, excellent handling and has an FDA-approved dye for enhanced visibility during surgery. Monoswift Plus is an antibacterial-coated, synthetic absorbable, sterile, monofilament surgical suture, composed of poly(glycolide-co-caprolactone) and features excellent holding strength, smooth tissue passage and superior handling. Visorb Plus is an antibacterial-coated, braided, synthetic absorbable surgical suture, composed of polyglycolic acid (PGA). It is available as both a dyed and undyed suture and features excellent tensile strength throughout the critical wound healing period. All products are available with or without needles.
CP Medical, along with NeedleTech Products and Galt Medical, comprise Theragenics’ surgical products business segment.
Theragenics Corporation manufactures and distributes wound closure, vascular access, and specialty needle products.